Dr. Sheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5255 Loughboro Road Northwest
Washington, DC 20016Phone+1 202-660-6500Fax+1 202-660-6501
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
Temple University HospitalResidency, Internal Medicine, 2013 - 2016
Rutgers New Jersey Medical SchoolClass of 2013
Certifications & Licensure
MD State Medical License 2016 - 2025
DC State Medical License 2022 - 2024
VA State Medical License 2023 - 2024
PA State Medical License 2013 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- NCCN Young Investigator Award National Comprehensive Cancer Network, 2020
- Inaugural Evelyn Lauder Young Investigator Award Breast Cancer Research Foundation and Conquer Cancer Foundation, 2019
Clinical Trials
- Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study Start of enrollment: 2021 Feb 08
Publications & Presentations
PubMed
- The challenge of weight gain in hormone receptor-positive breast cancer.Terrence C Tsou, Avonne Connor, Jennifer Y Sheng
Oncoscience. 2024-01-01 - Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions.Nada Lukkahatai, Jongmin Park, Hejingzi Monica Jia, Daniel Martin, Junxin Li
Biomedicines. 2023-11-16 - 1 citationsFeasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.Karen Lisa Smith, Hua-Ling Tsai, David Lim, Chenguang Wang, Raquel Nunes
JCO Oncology Practice. 2023-11-01
Press Mentions
Behind the Study: Weight Loss Strategies for Breast Cancer SurvivorsMarch 3rd, 2022- LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of IND for TT-01025, a SSAO/VAP-1 InhibitorDecember 1st, 2020
- NCCN Foundation Awards Leading Young Investigators Advancing Cancer Research for Adults and ChildrenMay 20th, 2020
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
